Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/27/2003US20030059338 Protecting from contaminants or pathogens with irradiation; biological sample is immunoglobulin, thrombin enzyme, antihemophilic factor, urokinase
03/27/2003US20030056700 Ultra fine fly ash and a system for collecting the same
03/27/2003CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2708349A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2492826A1 Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
03/27/2003CA2492823A1 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
03/27/2003CA2461056A1 Hiv-gag codon-optimised dna vaccines
03/27/2003CA2460713A1 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
03/27/2003CA2460629A1 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
03/27/2003CA2460587A1 Anti-pdgf antibodies and methods for producing engineered antibodies
03/27/2003CA2460558A1 Crustaceans as production systems for therapeutic proteins
03/27/2003CA2460456A1 Chromogenic in situ hybridization methods, kits, and compositions
03/27/2003CA2460392A1 Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity
03/27/2003CA2460321A1 Chemokines as adjuvants of immune response
03/27/2003CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2459969A1 Autologous t-cell vaccines materials and methods
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2457563A1 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/26/2003EP1295606A1 Curing method for pathologic syndrome and a medicinal preparation
03/26/2003EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
03/26/2003EP1294904A1 Heterodimeric fusion proteins
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294893A2 Modification of hepatitis b core antigen
03/26/2003EP1294892A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
03/26/2003EP1294891A2 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof
03/26/2003EP1294890A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
03/26/2003EP1294883A2 Human extracellular matrix (ecm)-related tumor marker
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294875A2 55p4h4: gene expressed in various cancers
03/26/2003EP1294858A2 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
03/26/2003EP1294857A2 Genetically modified t-cells, method for producing them and use thereof
03/26/2003EP1294771A2 IMMUNIZATION OF DAIRY CATTLE WITH CHIMERIC GAPC PROTEIN AGAINST i STREPTOCOCCUS /i INFECTION
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294764A2 Human receptors
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294726A2 Improvements in and relating to chromophores
03/26/2003EP1294646A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
03/26/2003EP1294401A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
03/26/2003EP1294400A1 Vaccine against foot-and-mouth disease
03/26/2003EP1294399A2 Methods and composition for oral vaccination
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294396A2 Contraceptive vaccines for pest control
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1042339B1 Carbohydrates, useful in solid delivery systems
03/26/2003EP0833658B1 Inhibin compositions and methods of enhancing production performance
03/26/2003EP0610436B9 Hepatitis-c virus testing
03/26/2003EP0431128B1 Vector coding for self-assembled, defective, non-self-propagating viral particles
03/26/2003EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof
03/26/2003CN1406277A Recombinant attenuation of PRRSV
03/26/2003CN1406249A Enhancing the circulating half-life of antibody-based fusion proteins
03/26/2003CN1406137A Caspase activated prodrugs therapy
03/26/2003CN1406136A Novel antibody with specificity for colon cancer
03/26/2003CN1406135A In ovo protection against infections bronchitis
03/26/2003CN1406132A Method for treating or inhibiting cellular injury or cell death
03/26/2003CN1406125A Method for transdermal or intradermal delivery of molecules
03/26/2003CN1404877A Blood-platelet specific mosaic immune globulin and its using method
03/26/2003CN1404876A Use of anti-CTLA anti-body
03/26/2003CN1404875A B-type hepatitis vaccine
03/26/2003CN1404874A Method for preparing thermal purifying-inactivating vaccine to bleeding of double-adicity vero cell kidney syndrome and use thereof
03/26/2003CN1404873A Typhoid vaccine
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103781C Abundant extracellular product and methods for production and use of same
03/26/2003CN1103603C Inactivated respiratory syncytial viral vaccines
03/25/2003USRE38046 (delayed type sensitivity) DTH-Effector cells are printed with carbohydrate antigens; antitumor
03/25/2003US6538127 Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria
03/25/2003US6538126 Polynucleotides of given sequence derived from CDNA
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538113 Methods of obtaining antibody directed against prothrombin fragments F2/F1+2
03/25/2003US6538110 Monoclonal antibodies against the interleukin 2 receptor
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537966 Follistatin-3
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537781 Methods and compositions concerning canine interleukin 5
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537559 Staphylococcus aureus antigen-containing whole cell vaccine
03/25/2003US6537557 Strain 341750 PDK-6
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537552 Vaccine adjuvant
03/25/2003US6537550 Preventing bacterial infection of lungs or bronchi in cystic fibrosis patient
03/25/2003US6537519 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
03/25/2003US6537265 Method for nasal application of a medicinal substance
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2088370C New use of monoclonal antibody
03/25/2003CA2079034C Respiratory disease vaccine for cats
1 ... 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 ... 1823